Christopher J. Langmead

About the Author

Christopher J. Langmead is a distinguished pharmacologist and researcher renowned for his expertise in G protein-coupled receptors (GPCRs) and their therapeutic potential. With a career spanning academia and industry, he has made significant contributions to understanding allosteric modulation as a strategy for drug discovery. As editor of 'From Structure to Clinical Development: Allosteric Modulation of G Protein-Coupled Receptors (Volume 88)' in the Advances in Pharmacology series, Langmead brings together leading experts to explore the structural biology, pharmacological mechanisms, and clinical applications of these vital targets. His work bridges fundamental science with practical drug development, influencing advancements in treatments for a range of diseases including neurological disorders and cardiovascular conditions. Langmead's insightful perspectives continue to shape the field of pharmacology.